Disability improvement with alemtuzumab is associated with durable improvement on functional assessment in multiple sclerosis scores over 4 years in CARE-MS II patients with RRMS though most were treatment-free after year 1
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Disability improvement with alemtuzumab is associated with durable improvement on functional assessment in multiple sclerosis scores over 4 years in CARE-MS II patients with RRMS though most were treatment-free after year 1 |
| Type de publication | Journal Article |
| Year of Publication | 2015 |
| Auteurs | Moreau T., R. Gonzalez A, Hartung H.-P, Hupperts R.MM, Kita M., Margolin D.H, Kasten L., Giovannoni G., Investigator CARE-MSII |
| Journal | MULTIPLE SCLEROSIS JOURNAL |
| Volume | 21 |
| Pagination | 564-565 |
| Date Published | SEP |
| Type of Article | Meeting Abstract |
| ISSN | 1352-4585 |